Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 [Phase 1, Phase 2]
Phase 1/2 trial of BNT411 in solid tumors and extensive-stage small cell lung cancer reported safety, pharmacokinetics, pharmacodynamics, an…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating QLS1209 in patients with advanced solid tumors. The trial status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Text-based Intervention to Minimize the Time Burden of Routine Cancer Care [NA]
A completed clinical trial from the Abramson Cancer Center evaluated a text-based intervention to reduce the time burden of routine cancer c…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors [Phase 1]
A Phase I clinical trial evaluating ROSE12 alone and in combination with other anti-tumor agents in patients with solid tumors is currently …
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Drug Interaction Study of SAR302503 in Patients With Solid Tumor [Phase 1]
Phase 1 drug interaction study of SAR302503 in patients with solid tumors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) [Phase 1, Phase 2]
CHAMP-1 is a Phase 1/2 study evaluating RNK05047 in adults with advanced solid tumors or diffuse large B-cell lymphoma, currently recruiting…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Trial of DFP-14927 in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating DFP-14927 in advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors [Phase 1]
Ascentage Pharma is conducting a Phase 1 trial of APG-115 alone or in combination with APG-2575 in children with recurrent or refractory neu…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase 1/2 study evaluating LM-302 in combination with toripalimab in patients with advanc…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating autologous tumor-infiltrating lymphocyte therapy for advanced solid tumors is currently recruiting, …
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer [Phase 1]
A Phase 1 study of ALRN-6924, a dual MDM2/MDMX inhibitor, in pediatric cancers has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3) [Phase 1, Phase 2]
Clinical trial update for TAC-T cells targeting Claudin 18.2 in metastatic solid tumors (TACTIC-3), a Phase 1/2 study. The trial is currentl…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction [Phase 1]
A Phase 1 trial evaluating trametinib in patients with advanced solid tumors, including those with liver metastases, with or without hepatic…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study [Phase 1]
Phase 1 pharmacokinetics study of sotrovimab as pre-exposure prophylaxis for COVID-19 in hematopoietic stem cell transplant recipients; the …
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors [Phase 1]
Phase 1 clinical trial update for CAN1012, a selective TLR7 agonist, in subjects with solid tumors, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating Onalespib in combination with AT7519 in patients with advanced, metastatic, or unresectable solid tumors has been c…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: TCR-engineered T Cells in Solid Tumors: IMA202-101 [Phase 1]
This report updates the completion of a Phase 1 trial of IMA202-101, a TCR-engineered T cell therapy, tested in adults with solid tumors. It…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) [Phase 1]
Phase 1 trial of IMA201-101 TCR-engineered T cells for solid tumors has been completed.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention [NA]
A pilot clinical trial evaluating whether an enhanced oncology nurse-led intervention can increase genetic testing uptake among adults with …
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Ixovex-1 Single Agent and Combination Therapy [Phase 1, Phase 2]
Ixovex-1 is being studied as a single-agent and combination therapy in Phase 1/Phase 2 trials for solid tumors including head and neck cance…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial of RC118 plus toripalimab or RC148 in locally advanced unresectable or metastatic solid tumors; recruiting.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor [Phase 1]
Phase I clinical trial update for BPI-16350 in patients with advanced solid tumors; the study is currently active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-01-15Clinical Trial Update: A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors [Phase 1]
A Phase 1 trial evaluating ASP1893 in adults with CLDN6-positive solid tumors has been withdrawn.
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]
Phase 1 trial of GNC-077 for gastrointestinal cancers and other solid tumors is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 study of ORIN1001 in patients with advanced solid tumor and relapsed/refractory metastatic breast cancer has completed the trial…